
The Evolving Pediatric Vaccine Schedule: Navigating New School Requirements
Expert discussion on how updated guidelines intersect with state vaccination requirements for school entry.
Episodes in this series

This roundtable series, Clinical Insights: Childhood Vaccine Schedule Changes, discusses ongoing changes to the pediatric vaccine schedule, the inner workings of the CDC’s Advisory Committee on Immunization Practices (ACIP), and how these changes are impacting US public health.
Recent revisions to the childhood immunization schedule have generated substantial discussion among clinicians, public health experts, and professional societies. Some updates involve shifts in recommendation status for several long-standing vaccines, including changes affecting routine use of
During a recent roundtable discussion, Jacinda Abdul-Mutakabbir, PharmD, MPH, of the University of California San Diego; Sharon Nachman, MD, of Stony Brook Children’s Hospital; Mary Koslap-Petraco, DNP, PNP-BC, CPNP, of Stony Brook University School of Nursing; and William Schaffner, MD, of Vanderbilt University School of Medicine reviewed these updates and their potential consequences. The experts emphasized that changes involving RSV prevention strategies,
Disclosures include Shionogi, GSK, NovaVax, CSL Sequiris, Innoviva Specialty Therapeutics, and Abbvie for Abdul-Mutakabbir.
References:
- CDC adopts individual-based decision-making for hepatitis B immunization for infants born to women who test negative for hepatitis B virus. News release. US Centers for Disease Control and Prevention. Published December 16, 2025. Accessed March 10, 2026.
https://www.cdc.gov/media/releases/2025/2025-hepatitis-b-immunization.html - Halsey G. ACIP votes to modify decades-long hepatitis B birth dose recommendation. Patient Care Online. December 5, 2025. Accessed March 10, 2026.
https://www.patientcareonline.com/view/acip-votes-to-modify-decades-long-hepatitis-b-birth-dose-recommendation








































































































































































